Feb 2, 2023Anavex Life Sciences Announces Exceeding of Enrollment Target for ANAVEX®2-73 (blarcamesine)
Jan 31, 2023Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023
Dec 14, 2022Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial
Dec 2, 2022Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022
Nov 28, 2022Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update
Nov 23, 2022Anavex Life Sciences to Announce Fiscal 2022 Year End Financial Results on Monday November 28, 2022